Abstract
BACKGROUND: To study in a phase I-II trial the maximum tolerated dose, the toxicity, and the tolerance of adding radiotherapy to systemic chemotherapy administered preoperatively in patients with locoregionally advanced gastric adenocarcinoma. PATIENTS AND METHODS: Patients with adenocarcinoma of the stomach (T(3)(-)(4)N(any) or T(any)N+), performance status
Original language | English |
---|---|
Pages (from-to) | 110-115 |
Number of pages | 6 |
Journal | Annals of Oncology |
Volume | 14 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jan 2003 |